Behandling med lansoprazol kan lede til en let øget risiko for gastrointestinale infektioner såsom Salmonella og Campylobacter.
Treatment with lansoprazole may lead to a slightly increased risk of gastrointestinal infections such as Salmonella and Campylobacter.